Coherus BioSciences Inc. (CHRS) |
|
20.36 0 (0%)
|
05-24 16:00 |
|
Open: |
20.58 |
Pre. Close: |
20.36 |
|
High:
|
20.6 |
Low:
|
19.8 |
|
Volume:
|
883,381 |
Market Cap:
|
1412M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
20.623 - 20.705 |
20.705 - 20.776 |
|
Low:
|
19.578 - 19.677 |
19.677 - 19.762 |
|
Close:
|
20.186 - 20.35 |
20.35 - 20.492 |
|
|
|
Technical analysis |
as of: 2019-05-26 10:09:46 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 24.74 One year: 28.89 |
| Support: |
Support1: 16.46 Support2: 13.55 |
| Resistance: |
Resistance1: 21.18 Resistance2: 24.74 |
| Pivot: |
17.96  |
| Moving Average: |
MA(5): 20.02 MA(20): 17.48
MA(100): 14.40 MA(250): 14.64 |
| MACD: |
MACD(12,26): 1.34 Signal(9): |
| Stochastic oscillator: |
%K(14,3): 87.12  %D(3): 89.84 |
| RSI: |
RSI(14): 77.81 |
| 52-week: |
High: 21.18 Low: 8.32 Change(%): 33.1 |
| Average Vol(K): |
3-Month: 89176 10-Days: 107551 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.CHRS has closed below upper band by 12.9%. Bollinger Bands are 119.1% wider than normal. The large width of the bands suggest high volatility as compared to CHRS's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Thu, 23 May 2019 17:12:48 Z
Amgen (AMGN) Offers to Acquire Drug Discovery Platform
Fri, 10 May 2019 01:58:12 Z
Coherus BioSciences, Inc. (CHRS) Q1 2019 Earnings Call Transcript
Thu, 09 May 2019 23:58:37 Z
Coherus BioSciences (CHRS) Reports Q1 Loss, Tops Revenue Estimates
Fri, 26 Apr 2019 13:22:34 Z
Moving Average Crossover Alert: Coherus BioSciences
Thu, 25 Apr 2019 15:19:52 Z
The Zacks Analyst Blog Highlights: Incyte, Aduro Biotech, MeiraGTx and Coherus BioSciences
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
69.37 |
| Shares Float (M) |
69.01 |
|
% Held by Insiders
|
0.60 |
|
% Held by Institutions
|
|
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-3.210 |
|
EPS Est. Current Year
|
-5.130 |
|
EPS Est. Next Year
|
-2.620 |
|
EPS Est. Next Quarter
|
-0.760 |
|
Forward EPS
|
-1.421 |
|
Book Value (p.s.)
|
74.180 |
|
PEG Ratio
|
-0.71 |
|
Profit Margin
|
|
|
Operating Margin
|
-472.05 |
|
Return on Assets (ttm)
|
-117.7 |
|
Return on Equity (ttm)
|
918.1 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-182.66 |
|
Levered Free Cash Flow (M)
|
-111.43 |
Stock Valuations |
|
P/E
|
-6.34 |
|
P/E Growth Ratio
|
|
|
P/BV
|
0.27 |
|
P/S
|
2567951360.00 |
|
P/CF
|
-7.73 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
